CA1243245A - Implantable demand medication delivery assembly - Google Patents
Implantable demand medication delivery assemblyInfo
- Publication number
- CA1243245A CA1243245A CA000489971A CA489971A CA1243245A CA 1243245 A CA1243245 A CA 1243245A CA 000489971 A CA000489971 A CA 000489971A CA 489971 A CA489971 A CA 489971A CA 1243245 A CA1243245 A CA 1243245A
- Authority
- CA
- Canada
- Prior art keywords
- assembly
- chamber
- reservoir
- pump
- recited
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M5/14244—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body
- A61M5/14276—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body specially adapted for implantation
- A61M5/1428—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body specially adapted for implantation with manual pumping action
Abstract
Abstract of the Invention An Implantable Demand Medication Delivery Assembly An implantable demand medication delivery assembly for delivering measured aliquots of liquid medication. The assembly includes a reservoir which stores the liquid medication to be delivered. The assembly also includes a pump which is in fluid communication with the reservoir. The pump includes a housing having an inlet port in fluid communication with the reservoir and an outlet port. Connected to the outlet port is a delivery catheter for delivering the liquid medication to a site within the patient wherein the assembly is implanted. The pump also includes a fluid passage which extends between the inlet and outlet port. A chamber is provided along the fluid passage for containing a preselected volume of liquid medication to be delivered. A resilient deformable wall on the pump extends over the chamber. A one-way valve is provided in the fluid passage between the inlet port and chamber for permitting fluid flow toward the chamber. A pressure regulated valve is provided in the fluid passage between the chamber and outlet port for selectively permitting fluid flow through the delivery catheter upon actuation of the pump. A
puncturable and resealable injection site can also be part of the assembly and, when part of the assembly, is in fluid communication with the reservoir.
puncturable and resealable injection site can also be part of the assembly and, when part of the assembly, is in fluid communication with the reservoir.
Description
An Implantable Demand Medication Deliver!l Assembly Background of the Invention The invention herein is directed to an implantable demand medication delivery assembly. In particular, the assembly is designed to be implanted in a patient who requires repeated injections of a particular medication or who requires delivery of a chemotherapeutic agent to a particular location within the patient. The assembly herein can be implanted in a patient and 10 thereby maintain the patient in an ambulatory state without the need for the patient to return to a clinic or hospital environment for treatments and the administration of medication.
There are many patients that have the need for the delivery of a specific dose of medication at various times. For example, many cancer 15 patients, such as those having terminal lower torso cancer, can have symptoms of chronic pain sufficient to render the patient immobile. One routine regimen for treating such patients is $he routine injection of morphine into the lumbar region of the patient either epidurally or intrathecally. Such morphine injections have been shown to relieve the 20 symptoms of pain, and in many instances, without adversely affecting the patient's mobiity or other routine and normal functions.
Another chronic ailment which requires routine injections is diabetes.
Diabetics require freguent dosages of insulin in the treatment of the chronic condition.
It would be desirable to provide an implantable assembly which can deli~rer a periodic bolus of medication to a specific anatomical area as required by the patient. It would be desirable to have such an assembly that can be operated by the patient. Such an assembly could be used to deliver morphine to the epidural or intrathecal space for pain relief, to 30 deliver chemotherapeutic agents into a feeding artery for cancer treat-ment, to deliver insulin for diabetics, and to deliver hormone agents for the treatment of sterility and the like.
Summary of the Invention 3~ The invention herein is directed to an implantable demand medication dslivery assembly. In particular, the assembly can be implanted in a ~Z'~3~
There are many patients that have the need for the delivery of a specific dose of medication at various times. For example, many cancer 15 patients, such as those having terminal lower torso cancer, can have symptoms of chronic pain sufficient to render the patient immobile. One routine regimen for treating such patients is $he routine injection of morphine into the lumbar region of the patient either epidurally or intrathecally. Such morphine injections have been shown to relieve the 20 symptoms of pain, and in many instances, without adversely affecting the patient's mobiity or other routine and normal functions.
Another chronic ailment which requires routine injections is diabetes.
Diabetics require freguent dosages of insulin in the treatment of the chronic condition.
It would be desirable to provide an implantable assembly which can deli~rer a periodic bolus of medication to a specific anatomical area as required by the patient. It would be desirable to have such an assembly that can be operated by the patient. Such an assembly could be used to deliver morphine to the epidural or intrathecal space for pain relief, to 30 deliver chemotherapeutic agents into a feeding artery for cancer treat-ment, to deliver insulin for diabetics, and to deliver hormone agents for the treatment of sterility and the like.
Summary of the Invention 3~ The invention herein is directed to an implantable demand medication dslivery assembly. In particular, the assembly can be implanted in a ~Z'~3~
-2- 489-~M
patient's body and provide a reservoir of a liquid medication which can be incrementally delivered to a specific site within the patient's body upon demand by ac tuation of the patient through application of an external force; i.e., finger pressure.
The implantable demand medication delivery assembly herein in-cludes a reservoir constructed of a biocompatible material which can be implanted in the patient1s body. The assembly also includes an implantable pump which is connected in fluid communication with the reservoir. The pump includes a reservoir chamber of a preselected volume which corre-sponds with the volume for a prescribed dosage of medication to be delivered. The reservoir chamber in the pump has a volume which will deliver the prescribed dosage.
The pump also includes a pressure regulated valve between the reservoir chamber and an outlet port on the pump. The pressure regulated valve maintains the liquid medication in the reservoir chamber and prevents its outflow until the pump is intentionally actuated by application of an external force, such as finger pressure. At the time the pump is actuated, the pressure in the reservoir chamber is sufficient to open the pressure regulated valve and permit the medication to flow through the outlet port.
The assembly also includes a one-way valve provided in the fluid passage between the reservoir and the reservoir chamber in the pump.
Such a one-way valve permits the flow of liguid medication into the reservoir chamber in the pump and prevents the flow of liquid medication from the reservoir chamber in the pump toward the reservoir itself. The presence of the one-way valve prevents the misdirection of the bolus of medication stored in the reservoir chamber in the pump. That is, the presence of the one-way valve insures that the dosage of liquid medication will be delivered through the outlet port of the pump rather than through the inlet port. Such a one-way valve can be a valve, such as a flap valve, present in the reservoir chamber of the pump and which occludes the fluid passage providing communication between the reservoir and the reservoir chamber in the pump. A flap valve can occlude the fluid passage when the proper volume of liquidmedication is present in the reservoir chamber of the pump. The one-way valve can also be a miter valve present in the fluid passage between the reservoir and the reservoir chamber of the pump.
~LZ'~3~
_3_ 489-VM
The pump includes a base and an upper wall. The upper wall includes a portion forming a dome, which dome portion is resilient and deformable.
The dome portion of the upper wall extends over and defines the reservoir chamber in the pump. Upon deformation of the dome portion of the upper wall, the dosage of liquid medication present in the reservoir chamber can be administered.
Extending around the dome portion of the upper wall can be a toroidal protrusion or extension of the upper wall. Such a toroidal shape of the upper wall encircles and surrounds the dome portion. The toroidal portion of the upper wall also extends to a height which is greater than the height of the dome portion of the upper wall. The greater height of the toroidal portion protects the dome portion from inadvertent deformation and thereby also inadvertent delivery of a dosage of medication. The toroidal portion of the upper wall permits palpation of the pump when the pump is implanted in a position where it can be palpated. A patient can thereby readily locate the pump and thereby also the dome portion upon which a force can be applied for actuating the pump and delivering the medication.
Connected to the outlet port of the pump is a delivery catheter. The delivery catheter is a tubuLqr conduit having a provided opening at its end or having an exit port through which the medication can be delivered to the appropriate site in the patient's body. For example, the catheter can be provided with either an opening or a slit which opens upon a preselected fluid pressure being achieved in the lumen of the delivery catheter~
The assembly can also include an injection site which can be implanted in the patient's body. Such an injection site is implanted such that it is in fluid communication with the reservoir. The presence of an injection site can provide for the replenishing of liquid medication in the reservoir. An injection site is a puncturable and resealable housing which can be punctured with a needle cannula of a syringe for introducing additional medication to the overall assembly and primarily the reservoir.
The liquid medication introduced through the injection site flows to the reservoir due to the presence of the one-way valve in the pump of the assembly.
patient's body and provide a reservoir of a liquid medication which can be incrementally delivered to a specific site within the patient's body upon demand by ac tuation of the patient through application of an external force; i.e., finger pressure.
The implantable demand medication delivery assembly herein in-cludes a reservoir constructed of a biocompatible material which can be implanted in the patient1s body. The assembly also includes an implantable pump which is connected in fluid communication with the reservoir. The pump includes a reservoir chamber of a preselected volume which corre-sponds with the volume for a prescribed dosage of medication to be delivered. The reservoir chamber in the pump has a volume which will deliver the prescribed dosage.
The pump also includes a pressure regulated valve between the reservoir chamber and an outlet port on the pump. The pressure regulated valve maintains the liquid medication in the reservoir chamber and prevents its outflow until the pump is intentionally actuated by application of an external force, such as finger pressure. At the time the pump is actuated, the pressure in the reservoir chamber is sufficient to open the pressure regulated valve and permit the medication to flow through the outlet port.
The assembly also includes a one-way valve provided in the fluid passage between the reservoir and the reservoir chamber in the pump.
Such a one-way valve permits the flow of liguid medication into the reservoir chamber in the pump and prevents the flow of liquid medication from the reservoir chamber in the pump toward the reservoir itself. The presence of the one-way valve prevents the misdirection of the bolus of medication stored in the reservoir chamber in the pump. That is, the presence of the one-way valve insures that the dosage of liquid medication will be delivered through the outlet port of the pump rather than through the inlet port. Such a one-way valve can be a valve, such as a flap valve, present in the reservoir chamber of the pump and which occludes the fluid passage providing communication between the reservoir and the reservoir chamber in the pump. A flap valve can occlude the fluid passage when the proper volume of liquidmedication is present in the reservoir chamber of the pump. The one-way valve can also be a miter valve present in the fluid passage between the reservoir and the reservoir chamber of the pump.
~LZ'~3~
_3_ 489-VM
The pump includes a base and an upper wall. The upper wall includes a portion forming a dome, which dome portion is resilient and deformable.
The dome portion of the upper wall extends over and defines the reservoir chamber in the pump. Upon deformation of the dome portion of the upper wall, the dosage of liquid medication present in the reservoir chamber can be administered.
Extending around the dome portion of the upper wall can be a toroidal protrusion or extension of the upper wall. Such a toroidal shape of the upper wall encircles and surrounds the dome portion. The toroidal portion of the upper wall also extends to a height which is greater than the height of the dome portion of the upper wall. The greater height of the toroidal portion protects the dome portion from inadvertent deformation and thereby also inadvertent delivery of a dosage of medication. The toroidal portion of the upper wall permits palpation of the pump when the pump is implanted in a position where it can be palpated. A patient can thereby readily locate the pump and thereby also the dome portion upon which a force can be applied for actuating the pump and delivering the medication.
Connected to the outlet port of the pump is a delivery catheter. The delivery catheter is a tubuLqr conduit having a provided opening at its end or having an exit port through which the medication can be delivered to the appropriate site in the patient's body. For example, the catheter can be provided with either an opening or a slit which opens upon a preselected fluid pressure being achieved in the lumen of the delivery catheter~
The assembly can also include an injection site which can be implanted in the patient's body. Such an injection site is implanted such that it is in fluid communication with the reservoir. The presence of an injection site can provide for the replenishing of liquid medication in the reservoir. An injection site is a puncturable and resealable housing which can be punctured with a needle cannula of a syringe for introducing additional medication to the overall assembly and primarily the reservoir.
The liquid medication introduced through the injection site flows to the reservoir due to the presence of the one-way valve in the pump of the assembly.
3~S
_4- 489-VM
Brief Description of the Drawings The implantable demand medication delivery assembly herein can be understood with regard to the following detailed description, accompanying claims and the accompanying drawings wherein:
FIGURE 1 is a side elevational view in cross section of a pump for use in the implantable demand medication delivery assembly herein;
FIGURE 2 is a top view in cross section of an implantable reservoir for use in the implantable demand medication delivery assembly herein;
and FIGURE 3 is a perspective view of the implantable demand medica-tion delivery assembly herein.
Detailed Description The implantable demand medication delivery assembly herein will be described with regard to the accompanying drawings. In particular, FIGURE 3 shows a perspective view of the implantable demand medication delivery assembly. The implantable demand medication delivery assembly includes a reservoir 42, an injection site 56, a pump 10, and a delivery catheter 40. In FIGURE 3, the relative sizes of the reservoir, injection site and pump are shown in one specific proportion, but for purposes of the implantable demand medication delivery assembly herein, the components can be of any particular size and volumes. For example, the reservoir is an expandable reservoir and is usually designed $o retain a sufficient volume of liquid medication for delivering incremental dosages thereof over an extended period of time.
In regard to FIGURE 3, the overall assembly herein includes a reservoir 42 for holding a 2redetermined volume of the liquid medication to be administered. The reservoir 42 includes an expandable wall 54 which can expand with inflation of the reservoir 42 due to the introduction of the liquid medication to the reservoir.
The reservoir 42 is in fluid communication through a tubular con-duit 52 with an inlet on a- puncturable and resealable injection site 56.
Such an injection site can include a puncturable and resealable dome 58.
The injection site includes an outlet which is in fluid com munication through a tubular conduit 52 with pump 10. With regard to FIGURE 3, the pump 10 includes an upper wall having an outer toroidal portion 20 s -5- 489-V~
encircling and extending above an inner dome portion 18. Extending from the pump is a delivery catheter 40 having a provided opening, such as a slit 41 at its tip.
The assembly is constructed of a biocompatible material such that it 5 can be readily implanted in a patient's body. A particularly preferred material for constructing the overall assembly is silicone elastomer as silicone elastomer has been proven to be substantially biocompatible with various environments in the body.
The pump 10 is the primary driving force in the assembly as it 10 receives the liquid medication, provides the proper volume of the liquid medication and delivers the prescribed volume OI medication as demanded.
The pump 10 is illustrated in FIGURE 1. FIGURE 1 shows an enlarged elevational view in section of the pump 10. With regard to FIGURE 1, the pump consists of a housing defined by a base 12 and a sidewall which, for 15 simplicity and ease of understanding, will be referred to as an upper wall attached to the base. The upper wall includes a first dome-shaped portion 18 and a second toroidal-shaped portion 20 encircling and extending above the dome-shaped portion 18. That is, the toroidal portion 20 extends to a greater height or elevation than the dome portion 18. The upper wall 20 is constructed of a resilient material, such as silicone; the upper wall being constructed of a resilient and elastomeric material in order to make the upper wall deformable and, in particular, the dome portion 18 readily deformable. ln order to prevent the inadvertent deformation of the dome portion 18, the toroidal portion 20 encircles and extends to a greater height 25 than the dome portion as shown in ~IGURE 1. Thus, any inadvertent bumping of the overall pump housing does not deform the dome portion 18 and thereby deliver an unnecessary dose of medication. The toroidal portion thereby provides an important safety feature in the pump assembly.
The pump includes an inlet port 14 providing a site for connection to 30 the appropriate tubular conduit for fluid communication between the pump and reservoir. The pump also includes an outlet port 16 which, through appropriate tubular connections, provides fluid now passage to the delivery catheter 40.
The pump includes a first fluid passage 24 which extends from the 35 inlet port 14 to a reservoir chamber 22 within the pump. As shown in FIGURE 1, the first fl~lid passage extends through a portion of the base of ~243~S
-6~ 489-VM
the pump. The reservoir chamber 22 is defined by the dome portion 18 of the upper wall and base member of the pump. The first ~luid passage 24 opens into the reservoir chamber 22 at a first port 2~ provided on the base portion of the pump. The reservoir chamber 22 can be of any preselected 5 size which provides the desired volume of liquid medication to be admin-istered upon actuation of the pump. The reservoir chamber 22 is constructed of a size and volume which approximates the volume of the prescribed dosage of medication to be delivered at any given time to the patient in which the overall assembly is implanted. Preferably, the 10 reservoir chamber is of a sufficiently small volume that more than one activation of the pump is required to deliver the prescribed unit dose of medication. Thus, if one dosage is administered inadvertently, it generally will not be of such a sufficient volume as to cause a problem, such as overdosing.
Provided along the first fluid passage either in the pump or along the tubing 52 is a one-way valve, such as a flap valve. The flap valve can be attached to the base of the pump and can lie within the reservoir chamber.
The flap valve can be attached along one edge such that it can open or close the first port 26 to fluid flow depending on whether a higher pressure is realized in the first flow passage 24 or in the reservoir chamber 22.
The one-way valve can also be a dome valve 28 which is attached along its periphery to the base. Such a dome valve 28 is illustrated in FIGURE 1. The dome valve 28 includes an opening 30 which is not aligned with the first port 26. The term "dome" is used merely to refer to the flap 25 valve being attached at its periphery and which allows flow beteen the flap and base and out through the opening. When the fluid pressure in the first flow passage 24 is greater than that in the reservoir chamber 22, fluid flows out of the first port between the valve 28 and base and into the chamber through the opening 30 in the valve. If the fluid pressure in the 30 reservoir chamber 22 is greater than the fluid pressure in the first fluid flow passage 24, then the fluid in the reservoir chamber exerts a force on the valve, occluding the passage between the valve and base, thereby preventing fluid flow out of or into the chamber. That is, the first port is effectively closed due to the presence of the desired volume of liquid 3~ medication in the reservoir chamber. The flap valve thus functions as an 3;~5 _7_ 489-VM
anti-backflow valve preventing flow from the chamber through the first port.
The pump also includes a second ~luid flow passage 34 which extends between the reservoir chamber 22 and an outlet port 16 on the pump. The 5 second fluid flow passage opens into the reservoir chamber through a second port 32 in the base. A pressure regulated valve is positioned in the second fluid flow passage 34. Such a valve can be any valve which opens at a preselected pressure being realized in the reservoir chamber 22. As the valve opens, the liquid medication in the reservoir chamber can flow out of 10 the reservoir chamber, through the second fluid flow passage, and out-wardly through the outlet port 16 on the pump. A preferred pressure regulated valve is a dome-shaped valve 36 which is provided in a valve chamber 38 along the second fluid flow passage 34 and which is open to the first fluid flow passage below the dome-shaped valve.
As shown in FIGURE 1, the dome-shaped valve 36 in the valve chamber 38 provides a pressure regulated valve. The domeffhaped valve is balanced against three pressures, namely the fluid pressure in the first fluid flow passage; the fluid pressure in the chamber; and the fluid pressure in the second fluid flow passage. The first fluid flow passage is open to 20 below the dome-shaped valve 36 and thereby e~hibits a fluid pressure which urges the dome-shaped valve against the second port 32, thereby occluding the port to fluid flow. Normally, the pressure in the first fluid flow passage is sufficient to maintain the dome-shaped valve in a closed position, closing the second port 32 to fluid flow. As a pressure is exerted 25 on the dome portion of the upper wall, a greater pressure is translated to the fluid within the chamber. At the time the fluid pressure in the chamber overcomes the pressure in the first fluid flow passage, the dome-shaped valve opens, thereby permitting fluid flow from the reservoir chamber 22, through the second port 32, and through the outlet port 16.
Connected to the outlet port 16 of the pump is a delivery cathe-ter 40. The delivery catheter includes an inner lumen through which the liquid medication is delivered. As can be seen in FIGURE 3, the delivery catheter 40 includes a provided opening or slit 41 which opens upon a preselected fluid pressure being realized within the lumen oi the delivery 35 catheter. The delivery tip of the delivery catheter can be placed adjacent ~l~432~S
the site in the patient's body to which medication is to be delivered.
Thus, the medication can be deLivered directLy to such a site for optLmum effect.
Attached and connected in fLuid flow com~unication with the inLet port 14 of the pump is a t~iLar conduit 52. The tubu~Lar conduit is attached also to the reservoir 42. ~Lternatively, an injection site assembly can be interconnected between the pump and reservoir along the tubular conduit as is hown in FIGURE 3. The reservoir 42 includes a base member 50 to which is attached an expansible sheet or sidew~LLl 54. The sidewall 54 is bonded to the base member 50 for providing a liquid-tight sea;L between the sidewall and base mRmber. m e sidewaLl 54 can expand or inflate to hold a sufficient volume of liquid medication from which an aliquot can be deliversd to the patient thrcugh the pump. Ihe sidewall 54 and base member 50 form a reservoir chamber 44 in the reservoir 42. The reservoir chamber 44 can be of any desired size depending upon the use of the overall assembly, expected time the assembly is to remain implanted in the patient, and volumes of the incremental doses of medication to be delivered over such time. P3sitioned within the reservoir ch~mker 44 is a collection tube 46. Such a collection tube cxul be a perforated tube having perforations 48 provided on its surfaoe and opening into the lumen of the collection tube. Preferably, the collection tube 46 is positioned such that it lies within the chamber and is positioned along the perimeter of the reservoir chamber 44. In such an arrangement, the collection tube can collect substantially all of the liquid medication in the reservoir chamber 44 regardless of the orientation of ~he ~hamber and reservoir 42.
The tubular conduit 52 connects with the collection tube 46. The tubular conduit 52 can be interrupbei and have pravided along its length an MIS/lcm - ~12~ 5 injection site 56. The injection site can be any implan W le injection site, such as di~closed in U.S. Patent No. ~,190,040 of Schulte entitled alable Puncture Hcusing For Surgical I~plantation".
The mjection site includes a dome 58 which can be punctured with a needle cannula and, upon withdrawal of the needle cannula, reseals to prevent leakage. The use of ~l injection site along the tubular conduit 52 prcvides a method for refilling the reservoir ~2 with additional liquid medication after the overall assembly has been implanted in a patient. The - 8a -MlS/lcm ~Z~3~
injection site can be connected directly to the reservoir rather than in-line between the reservoir and pump.
To use the implantable demand medication delivery assembly herein, the entire assembly is implanted in a patient. As stated earlier, the entire 5 assembly can be constructed of a biocompatible material, such as silicone elastomer. The delivery catheter 40 is implanted such that its tip is adiacent the site to which the liquid medication is to be delivered. The delivery catheter can have any length. It is preferred to implant the pump in a readily accesible location so that it can be actuated by the patient. It 10 is also desirable to provide the pump in a location where it will be somewhat inconspicuous and also will not be inadvertently bumped so as to cause an inadvertent delivery of medication. However, the design of the pump generally avoids such an inadvertent delivery.
After implantation, when the patient feels a need for delivery of 15 medication or when a prescribed time period has elapsed so that a dosage of medication can be delivered, the patient depresses the dome portion 18 on the pump. The depression of the dome causes collapse of the dome in upon the reservoir chamber 22 in the pump, causing the liquid medication in the reservoir chamber 22 to flow through the second port 32, past the 2~ then open pressure regulated valve 36, and outwardly through the second fluid passage 34 and through the delivery conduit 40. The one-way valve 28 prevents the liquid medication in the reservoir chamber 22 from flowing through the first fluid passage 24. As the pressure on the dome portion 18 is relaxed, the dome portion 18 recovers to its original shape, causing a 25 reduced pressure in the reservoir chamber 22. The reduced pressure draws additional liquid medication from the reservoir 42 through the tubular conduit 52 connecting the reservoir to the pump and through the one-way valve 28. Liquid medication is drawn into $he reservoir chamber 22 of the pump until it has substantially filled the reservoir chamber with the desired 30 aliquot of medication. The pressure regulated valve 38 also recovers closing the second port 32 to fluid flow, thereby retaining the new dosage of liquid medication in the reservoir chamber 22. Subsequently, as the patient requires an additional dosage of medication, the dome portion of the pump can again be depressed to deliver the liquid medication and the 35 cycle is repeated.
3~'~S
In the event the liquid medication stored in the reservoir 42 becomes depleted and the patient continues to have Q need for the assembly and delivery of medication, then a syringe filled with additional liquid medica-tion can be used to replenish the liquid medication in the reservoir. The 5 injection site 56 is palpated to determine its location. Once the injection site h&s been located, the injection site can be pierced with the needle cannula of the syringe. Additional liquid medication can then be injected into the injection site. The added liquid medication flows from the injection site into the reservoir 42. The liquid medication is prevented 10 from flowing into and through the pump 10 due to the one-way valve present in the pump. The fluid pressure due to the presence of liquid medication in the reservoir chamber 22 of the pump maintains the one-way valve 28 closed, thereby occluding fluid flow through the first port out of the chamber. The fluid pressure in the first fluid flow passage and below 15 the dome~haped valve maintains the second port closed to fluid flow. The liquid medication introduced into the injection site, therefore, flows into the reservoir chamber 44 of the reservoir 42.
_4- 489-VM
Brief Description of the Drawings The implantable demand medication delivery assembly herein can be understood with regard to the following detailed description, accompanying claims and the accompanying drawings wherein:
FIGURE 1 is a side elevational view in cross section of a pump for use in the implantable demand medication delivery assembly herein;
FIGURE 2 is a top view in cross section of an implantable reservoir for use in the implantable demand medication delivery assembly herein;
and FIGURE 3 is a perspective view of the implantable demand medica-tion delivery assembly herein.
Detailed Description The implantable demand medication delivery assembly herein will be described with regard to the accompanying drawings. In particular, FIGURE 3 shows a perspective view of the implantable demand medication delivery assembly. The implantable demand medication delivery assembly includes a reservoir 42, an injection site 56, a pump 10, and a delivery catheter 40. In FIGURE 3, the relative sizes of the reservoir, injection site and pump are shown in one specific proportion, but for purposes of the implantable demand medication delivery assembly herein, the components can be of any particular size and volumes. For example, the reservoir is an expandable reservoir and is usually designed $o retain a sufficient volume of liquid medication for delivering incremental dosages thereof over an extended period of time.
In regard to FIGURE 3, the overall assembly herein includes a reservoir 42 for holding a 2redetermined volume of the liquid medication to be administered. The reservoir 42 includes an expandable wall 54 which can expand with inflation of the reservoir 42 due to the introduction of the liquid medication to the reservoir.
The reservoir 42 is in fluid communication through a tubular con-duit 52 with an inlet on a- puncturable and resealable injection site 56.
Such an injection site can include a puncturable and resealable dome 58.
The injection site includes an outlet which is in fluid com munication through a tubular conduit 52 with pump 10. With regard to FIGURE 3, the pump 10 includes an upper wall having an outer toroidal portion 20 s -5- 489-V~
encircling and extending above an inner dome portion 18. Extending from the pump is a delivery catheter 40 having a provided opening, such as a slit 41 at its tip.
The assembly is constructed of a biocompatible material such that it 5 can be readily implanted in a patient's body. A particularly preferred material for constructing the overall assembly is silicone elastomer as silicone elastomer has been proven to be substantially biocompatible with various environments in the body.
The pump 10 is the primary driving force in the assembly as it 10 receives the liquid medication, provides the proper volume of the liquid medication and delivers the prescribed volume OI medication as demanded.
The pump 10 is illustrated in FIGURE 1. FIGURE 1 shows an enlarged elevational view in section of the pump 10. With regard to FIGURE 1, the pump consists of a housing defined by a base 12 and a sidewall which, for 15 simplicity and ease of understanding, will be referred to as an upper wall attached to the base. The upper wall includes a first dome-shaped portion 18 and a second toroidal-shaped portion 20 encircling and extending above the dome-shaped portion 18. That is, the toroidal portion 20 extends to a greater height or elevation than the dome portion 18. The upper wall 20 is constructed of a resilient material, such as silicone; the upper wall being constructed of a resilient and elastomeric material in order to make the upper wall deformable and, in particular, the dome portion 18 readily deformable. ln order to prevent the inadvertent deformation of the dome portion 18, the toroidal portion 20 encircles and extends to a greater height 25 than the dome portion as shown in ~IGURE 1. Thus, any inadvertent bumping of the overall pump housing does not deform the dome portion 18 and thereby deliver an unnecessary dose of medication. The toroidal portion thereby provides an important safety feature in the pump assembly.
The pump includes an inlet port 14 providing a site for connection to 30 the appropriate tubular conduit for fluid communication between the pump and reservoir. The pump also includes an outlet port 16 which, through appropriate tubular connections, provides fluid now passage to the delivery catheter 40.
The pump includes a first fluid passage 24 which extends from the 35 inlet port 14 to a reservoir chamber 22 within the pump. As shown in FIGURE 1, the first fl~lid passage extends through a portion of the base of ~243~S
-6~ 489-VM
the pump. The reservoir chamber 22 is defined by the dome portion 18 of the upper wall and base member of the pump. The first ~luid passage 24 opens into the reservoir chamber 22 at a first port 2~ provided on the base portion of the pump. The reservoir chamber 22 can be of any preselected 5 size which provides the desired volume of liquid medication to be admin-istered upon actuation of the pump. The reservoir chamber 22 is constructed of a size and volume which approximates the volume of the prescribed dosage of medication to be delivered at any given time to the patient in which the overall assembly is implanted. Preferably, the 10 reservoir chamber is of a sufficiently small volume that more than one activation of the pump is required to deliver the prescribed unit dose of medication. Thus, if one dosage is administered inadvertently, it generally will not be of such a sufficient volume as to cause a problem, such as overdosing.
Provided along the first fluid passage either in the pump or along the tubing 52 is a one-way valve, such as a flap valve. The flap valve can be attached to the base of the pump and can lie within the reservoir chamber.
The flap valve can be attached along one edge such that it can open or close the first port 26 to fluid flow depending on whether a higher pressure is realized in the first flow passage 24 or in the reservoir chamber 22.
The one-way valve can also be a dome valve 28 which is attached along its periphery to the base. Such a dome valve 28 is illustrated in FIGURE 1. The dome valve 28 includes an opening 30 which is not aligned with the first port 26. The term "dome" is used merely to refer to the flap 25 valve being attached at its periphery and which allows flow beteen the flap and base and out through the opening. When the fluid pressure in the first flow passage 24 is greater than that in the reservoir chamber 22, fluid flows out of the first port between the valve 28 and base and into the chamber through the opening 30 in the valve. If the fluid pressure in the 30 reservoir chamber 22 is greater than the fluid pressure in the first fluid flow passage 24, then the fluid in the reservoir chamber exerts a force on the valve, occluding the passage between the valve and base, thereby preventing fluid flow out of or into the chamber. That is, the first port is effectively closed due to the presence of the desired volume of liquid 3~ medication in the reservoir chamber. The flap valve thus functions as an 3;~5 _7_ 489-VM
anti-backflow valve preventing flow from the chamber through the first port.
The pump also includes a second ~luid flow passage 34 which extends between the reservoir chamber 22 and an outlet port 16 on the pump. The 5 second fluid flow passage opens into the reservoir chamber through a second port 32 in the base. A pressure regulated valve is positioned in the second fluid flow passage 34. Such a valve can be any valve which opens at a preselected pressure being realized in the reservoir chamber 22. As the valve opens, the liquid medication in the reservoir chamber can flow out of 10 the reservoir chamber, through the second fluid flow passage, and out-wardly through the outlet port 16 on the pump. A preferred pressure regulated valve is a dome-shaped valve 36 which is provided in a valve chamber 38 along the second fluid flow passage 34 and which is open to the first fluid flow passage below the dome-shaped valve.
As shown in FIGURE 1, the dome-shaped valve 36 in the valve chamber 38 provides a pressure regulated valve. The domeffhaped valve is balanced against three pressures, namely the fluid pressure in the first fluid flow passage; the fluid pressure in the chamber; and the fluid pressure in the second fluid flow passage. The first fluid flow passage is open to 20 below the dome-shaped valve 36 and thereby e~hibits a fluid pressure which urges the dome-shaped valve against the second port 32, thereby occluding the port to fluid flow. Normally, the pressure in the first fluid flow passage is sufficient to maintain the dome-shaped valve in a closed position, closing the second port 32 to fluid flow. As a pressure is exerted 25 on the dome portion of the upper wall, a greater pressure is translated to the fluid within the chamber. At the time the fluid pressure in the chamber overcomes the pressure in the first fluid flow passage, the dome-shaped valve opens, thereby permitting fluid flow from the reservoir chamber 22, through the second port 32, and through the outlet port 16.
Connected to the outlet port 16 of the pump is a delivery cathe-ter 40. The delivery catheter includes an inner lumen through which the liquid medication is delivered. As can be seen in FIGURE 3, the delivery catheter 40 includes a provided opening or slit 41 which opens upon a preselected fluid pressure being realized within the lumen oi the delivery 35 catheter. The delivery tip of the delivery catheter can be placed adjacent ~l~432~S
the site in the patient's body to which medication is to be delivered.
Thus, the medication can be deLivered directLy to such a site for optLmum effect.
Attached and connected in fLuid flow com~unication with the inLet port 14 of the pump is a t~iLar conduit 52. The tubu~Lar conduit is attached also to the reservoir 42. ~Lternatively, an injection site assembly can be interconnected between the pump and reservoir along the tubular conduit as is hown in FIGURE 3. The reservoir 42 includes a base member 50 to which is attached an expansible sheet or sidew~LLl 54. The sidewall 54 is bonded to the base member 50 for providing a liquid-tight sea;L between the sidewall and base mRmber. m e sidewaLl 54 can expand or inflate to hold a sufficient volume of liquid medication from which an aliquot can be deliversd to the patient thrcugh the pump. Ihe sidewall 54 and base member 50 form a reservoir chamber 44 in the reservoir 42. The reservoir chamber 44 can be of any desired size depending upon the use of the overall assembly, expected time the assembly is to remain implanted in the patient, and volumes of the incremental doses of medication to be delivered over such time. P3sitioned within the reservoir ch~mker 44 is a collection tube 46. Such a collection tube cxul be a perforated tube having perforations 48 provided on its surfaoe and opening into the lumen of the collection tube. Preferably, the collection tube 46 is positioned such that it lies within the chamber and is positioned along the perimeter of the reservoir chamber 44. In such an arrangement, the collection tube can collect substantially all of the liquid medication in the reservoir chamber 44 regardless of the orientation of ~he ~hamber and reservoir 42.
The tubular conduit 52 connects with the collection tube 46. The tubular conduit 52 can be interrupbei and have pravided along its length an MIS/lcm - ~12~ 5 injection site 56. The injection site can be any implan W le injection site, such as di~closed in U.S. Patent No. ~,190,040 of Schulte entitled alable Puncture Hcusing For Surgical I~plantation".
The mjection site includes a dome 58 which can be punctured with a needle cannula and, upon withdrawal of the needle cannula, reseals to prevent leakage. The use of ~l injection site along the tubular conduit 52 prcvides a method for refilling the reservoir ~2 with additional liquid medication after the overall assembly has been implanted in a patient. The - 8a -MlS/lcm ~Z~3~
injection site can be connected directly to the reservoir rather than in-line between the reservoir and pump.
To use the implantable demand medication delivery assembly herein, the entire assembly is implanted in a patient. As stated earlier, the entire 5 assembly can be constructed of a biocompatible material, such as silicone elastomer. The delivery catheter 40 is implanted such that its tip is adiacent the site to which the liquid medication is to be delivered. The delivery catheter can have any length. It is preferred to implant the pump in a readily accesible location so that it can be actuated by the patient. It 10 is also desirable to provide the pump in a location where it will be somewhat inconspicuous and also will not be inadvertently bumped so as to cause an inadvertent delivery of medication. However, the design of the pump generally avoids such an inadvertent delivery.
After implantation, when the patient feels a need for delivery of 15 medication or when a prescribed time period has elapsed so that a dosage of medication can be delivered, the patient depresses the dome portion 18 on the pump. The depression of the dome causes collapse of the dome in upon the reservoir chamber 22 in the pump, causing the liquid medication in the reservoir chamber 22 to flow through the second port 32, past the 2~ then open pressure regulated valve 36, and outwardly through the second fluid passage 34 and through the delivery conduit 40. The one-way valve 28 prevents the liquid medication in the reservoir chamber 22 from flowing through the first fluid passage 24. As the pressure on the dome portion 18 is relaxed, the dome portion 18 recovers to its original shape, causing a 25 reduced pressure in the reservoir chamber 22. The reduced pressure draws additional liquid medication from the reservoir 42 through the tubular conduit 52 connecting the reservoir to the pump and through the one-way valve 28. Liquid medication is drawn into $he reservoir chamber 22 of the pump until it has substantially filled the reservoir chamber with the desired 30 aliquot of medication. The pressure regulated valve 38 also recovers closing the second port 32 to fluid flow, thereby retaining the new dosage of liquid medication in the reservoir chamber 22. Subsequently, as the patient requires an additional dosage of medication, the dome portion of the pump can again be depressed to deliver the liquid medication and the 35 cycle is repeated.
3~'~S
In the event the liquid medication stored in the reservoir 42 becomes depleted and the patient continues to have Q need for the assembly and delivery of medication, then a syringe filled with additional liquid medica-tion can be used to replenish the liquid medication in the reservoir. The 5 injection site 56 is palpated to determine its location. Once the injection site h&s been located, the injection site can be pierced with the needle cannula of the syringe. Additional liquid medication can then be injected into the injection site. The added liquid medication flows from the injection site into the reservoir 42. The liquid medication is prevented 10 from flowing into and through the pump 10 due to the one-way valve present in the pump. The fluid pressure due to the presence of liquid medication in the reservoir chamber 22 of the pump maintains the one-way valve 28 closed, thereby occluding fluid flow through the first port out of the chamber. The fluid pressure in the first fluid flow passage and below 15 the dome~haped valve maintains the second port closed to fluid flow. The liquid medication introduced into the injection site, therefore, flows into the reservoir chamber 44 of the reservoir 42.
Claims (21)
1. An implantable demand medication delivery assembly com-prising:
a reservoir means for storing a liquid medication to be delivered;
a pump means in fluid communication with the reservoir means for pumping a selected volume of the liquid medication, the pump means comprising:
a housing having an inlet port in fluid communi-cation with the reservoir means and an outlet port;
a fluid passage extending between the inlet port and outlet port;
a chamber along the fluid passage for containing a preselected volume of liquid medication to be delivered;
a resilient deformable wall extending over the chamber;
a one-way valve means in the fluid passage between the inlet port and chamber for permiting fluid flow toward the chamber; and a pressure regulated valve means in the fluid passage between the chamber and outlet port for selectively permitting fluid flow through such fluid passage at preselected fluid pressures; and a delivery catheter means connected to the outlet port of the pump means for delivering the liquid medication to a location spaced from the pump means.
a reservoir means for storing a liquid medication to be delivered;
a pump means in fluid communication with the reservoir means for pumping a selected volume of the liquid medication, the pump means comprising:
a housing having an inlet port in fluid communi-cation with the reservoir means and an outlet port;
a fluid passage extending between the inlet port and outlet port;
a chamber along the fluid passage for containing a preselected volume of liquid medication to be delivered;
a resilient deformable wall extending over the chamber;
a one-way valve means in the fluid passage between the inlet port and chamber for permiting fluid flow toward the chamber; and a pressure regulated valve means in the fluid passage between the chamber and outlet port for selectively permitting fluid flow through such fluid passage at preselected fluid pressures; and a delivery catheter means connected to the outlet port of the pump means for delivering the liquid medication to a location spaced from the pump means.
2. An assembly as recited in claim 1 wherein the housing of the pump means comprises a base member and a resilient sidewall fastened to the base member, the sidewall including a flexible resilient dome portion extending over the chamber and protective means for preventing inad-vertent compression of the dome portion.
3. An assembly as recited in claim 2 wherein the protective means comprises a toroidal extension of the sidewall which projects beyond and encircles the flexible resilient dome portion.
4. An assembly as recited in claim 1 wherein the one-way valve means comprises a flap valve extending over a first port in the fluid passage and opening into the chamber whereby the presence of liquid in the chamber can exert a force on the flap valve and urge it against the first port to close the first port to fluid flow from the chamber.
5. An assembly as recited in claim 4 wherein the flap valve comprises a dome-shaped valve having an aperture therein and attached along its periphery to a wall of the chamber extending around the first port wherein the aperture and first port are misaligned such that a preselected fluid pressure in the chamber closes the flap valve to fluid flow.
6. An assembly as recited in claim 1 wherein the reservoir means comprises a resilient-walled, enclosed envelope defining a reservoir chamber therein and a length of perforated tubing in the chamber, which perforated tubing communicates with a tubular conduit extending between the reservoir means and inlet port of the pump means.
7. An assembly as recited in claim 6 wherein the length of perforated tubing extends along the periphery of the reservoir chamber.
8. An assembly as recited in claim 1 further comprising an implantable resealable injection site positioned in fluid communication with the reservoir means.
9. An assembly as recited in claim 8 wherein the injection site is provided between the reservoir means and the pump means along a tubular fluid passage conduit in fluid communication with the reservoir means and pump means.
10. An implantable demand medication delivery assembly com-prising:
a reservoir means for storing a liquid medication to be delivered;
a pump means in fluid communication with the reservoir means for pumping a preselected volume of the liquid medica-tion, the pump means comprising:
a base member defining a first fluid passage extending from an inlet port to a first port opening on an upper surface of the base member and a second fluid passage extending between a second port opening in the upper surface of the base member to an outlet port;
a resilient wall attached to the base member including an encircling dome portion extending over the first and second port openings of the base member to define a chamber between the resilient wall and base member; and a pressure regulated valve means in the second fluid passage for opening to permit fluid flow through the second fluid passage at pre-selected fluid pressures in the chamber upon actuation of the pump means; and a delivery catheter means connected to the outlet port of the pump means for delivering the liquid medication to a location spaced from the pump means.
a reservoir means for storing a liquid medication to be delivered;
a pump means in fluid communication with the reservoir means for pumping a preselected volume of the liquid medica-tion, the pump means comprising:
a base member defining a first fluid passage extending from an inlet port to a first port opening on an upper surface of the base member and a second fluid passage extending between a second port opening in the upper surface of the base member to an outlet port;
a resilient wall attached to the base member including an encircling dome portion extending over the first and second port openings of the base member to define a chamber between the resilient wall and base member; and a pressure regulated valve means in the second fluid passage for opening to permit fluid flow through the second fluid passage at pre-selected fluid pressures in the chamber upon actuation of the pump means; and a delivery catheter means connected to the outlet port of the pump means for delivering the liquid medication to a location spaced from the pump means.
11. An assembly as recited in claim 10 wherein the resilient wall of the pump means further comprises a barrier portion for inhibiting the inadvertent compression of the dome portion.
12. An assembly as recited in claim 11 wherein such barrier portion of the resilient wall comprises a toroidal extension of the resilient wall extending beyond and encircling the dome portion.
13. An assembly as recited in claim 10 further comprising a one-way valve positioned along the first fluid passage.
14. An assembly as recited in claim 13 wherein the one-way valve comprises a flap valve extending over the first port.
15. An assembly as recited in claim 14 wherein the flap valve comprises a dome-shaped valve attached along its periphery to a wall of the chamber having an aperture therein, which valve extends over the first port and the aperture and first port are misaligned such that a preselected fluid pressure in the chamber closes the valve to fluid flow from the chamber.
16. an assembly as recited in claim 10 wherein the pressure regulated valve means comprises a dome valve in a valve chamber along the second fluid passage.
17. An assembly as recited in claim 10 wherein the reservoir means comprises a resilient-walled, enclosed envelope defining a reservoir chamber therein and a length of perforated tubing in the chamber, which perforated tubing communicates with a tubular conduit extending between the reservoir means and inlet port of the pump means.
18. An assembly as recited in claim 17 wherein the length of perforated tubing extends along the periphery of the reservoir chamber.
19. An assembly as recited in claim 10 further comprising an implantable resealable injection site positioned in fluid communication with the reservoir means.
20. An assembly as recited in claim 19 wherein the injection site is provided between the reservoir means and the pump means along a tubular fluid passage conduit in fluid communication with the reservoir means and pump means.
21. An assembly as recited in claim 16 wherein the dome valve references three pressures such that increased pressure in the first fluid passage tends to urge closed the valve thus preventing flow through the device.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/646,998 US4634427A (en) | 1984-09-04 | 1984-09-04 | Implantable demand medication delivery assembly |
| US646,998 | 1991-01-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1243245A true CA1243245A (en) | 1988-10-18 |
Family
ID=24595295
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA000489971A Expired CA1243245A (en) | 1984-09-04 | 1985-09-04 | Implantable demand medication delivery assembly |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US4634427A (en) |
| EP (1) | EP0174757A1 (en) |
| JP (1) | JPS61113469A (en) |
| CA (1) | CA1243245A (en) |
| DE (1) | DE174757T1 (en) |
Families Citing this family (209)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4761158A (en) * | 1984-03-16 | 1988-08-02 | Pudenz-Schulte Medical Research Corp. | Subcutaneous infusion reservoir and pump system |
| US4816016A (en) * | 1984-03-16 | 1989-03-28 | Pudenz-Schulte Medical Research Corp. | Subcutaneous infusion reservoir and pump system |
| EP0392566A1 (en) * | 1984-10-01 | 1990-10-17 | Cook Incorporated | Implantable insulin administration device |
| AU595540B2 (en) * | 1985-08-06 | 1990-04-05 | Baxter International Inc. | Patient-controlled delivery of beneficial agents |
| FR2599260A1 (en) * | 1986-04-24 | 1987-12-04 | Centre Nat Rech Scient | RECHARGEABLE IMPLANTABLE DEVICE FOR DOSED AND REPEATED MEDICINAL SELF INJECTION |
| US4766889A (en) * | 1986-06-26 | 1988-08-30 | Medical Engineering Corporation | Infusion erectile system |
| CA1284753C (en) * | 1986-09-12 | 1991-06-11 | Gordon Hiroshi Sasaki | Lozenge-shaped low profile injection reservoir |
| US4904241A (en) * | 1986-10-16 | 1990-02-27 | Medical Engineering Corp. | Septum with a needle stop at the fluid transfer port |
| US4795437A (en) * | 1987-01-29 | 1989-01-03 | Pudenz-Schulte Medical Research Corporation | Siphon control device |
| US4781680A (en) * | 1987-03-02 | 1988-11-01 | Vir Engineering | Resealable injection site |
| US4813951A (en) * | 1987-05-20 | 1989-03-21 | Joel Wall | Self-actuated implantable pump |
| US5324256A (en) * | 1987-07-31 | 1994-06-28 | Lawrence A. Lynn | Apparatus and methods for transferring blood between aspiration assembly and an external container |
| US5178607A (en) * | 1987-07-31 | 1993-01-12 | Lynn Lawrence A | Blood aspiration assembly septum and blunt needle aspirator |
| US4838855A (en) * | 1987-07-31 | 1989-06-13 | Lynn Lawrence A | Blood aspiration assembly and method |
| US4898584A (en) * | 1988-05-18 | 1990-02-06 | Baxter Healthcare Corporation | Implantable patient-activated fluid delivery device |
| US4898583A (en) * | 1988-05-18 | 1990-02-06 | Baxter Healthcare Corporation | Implantable patient-activated fluid delivery device and outlet valve therefor |
| US4898585A (en) * | 1988-05-18 | 1990-02-06 | Baxter Healthcare Corporation | Implantable patient-activated fluid delivery device with bolus injection port |
| US5011477A (en) * | 1989-04-21 | 1991-04-30 | Baxter International Inc. | Continuous/bolus infusor |
| CA2070633A1 (en) * | 1989-12-05 | 1991-06-06 | Brian D. Zdeb | Self-driven pump device |
| US5232448A (en) * | 1989-12-05 | 1993-08-03 | Prime Medical Products | Patient-controlled analgesia device |
| US5137529A (en) * | 1990-02-20 | 1992-08-11 | Pudenz-Schulte Medical Research Corporation | Injection port |
| US5152753A (en) * | 1990-04-02 | 1992-10-06 | Pudenz-Schulte Medical Research Corporation | Medication infusion device with dose recharge restriction |
| US5085644A (en) * | 1990-04-02 | 1992-02-04 | Pudenz-Schulte Medical Research Corporation | Sterilizable medication infusion device with dose recharge restriction |
| US5405325A (en) * | 1991-10-17 | 1995-04-11 | Labs; Joseph D. | Access graft |
| US6358239B1 (en) * | 1992-01-24 | 2002-03-19 | I-Flow Corporation | Platen pump |
| US6251098B1 (en) | 1992-01-24 | 2001-06-26 | I-Flow, Corp. | Fluid container for use with platen pump |
| US20080215029A1 (en) * | 1993-01-22 | 2008-09-04 | I-Flow Corporation | Platen pump |
| US6063025A (en) * | 1993-07-09 | 2000-05-16 | Bioenterics Corporation | Apparatus for holding intestines out of an operative field |
| DE4402380A1 (en) * | 1994-01-27 | 1995-08-03 | Hans Peter Prof Dr Med Zenner | Implantable dosing system |
| US5522804A (en) * | 1994-02-15 | 1996-06-04 | Lynn; Lawrence A. | Aspiration, mixing, and injection syringe |
| US5759160A (en) * | 1995-11-20 | 1998-06-02 | Utah Medical Products, Inc. | Blood sampling system |
| US6558900B2 (en) * | 1996-07-12 | 2003-05-06 | Emory University | Regulation of apoptosis and in vitro model for studies thereof |
| US5906597A (en) | 1998-06-09 | 1999-05-25 | I-Flow Corporation | Patient-controlled drug administration device |
| US8177762B2 (en) * | 1998-12-07 | 2012-05-15 | C. R. Bard, Inc. | Septum including at least one identifiable feature, access ports including same, and related methods |
| US6485461B1 (en) | 2000-04-04 | 2002-11-26 | Insulet, Inc. | Disposable infusion device |
| DE10026172A1 (en) * | 2000-05-26 | 2001-11-29 | Roche Diagnostics Gmbh | Body fluid withdrawal system |
| US6669669B2 (en) | 2001-10-12 | 2003-12-30 | Insulet Corporation | Laminated patient infusion device |
| CA2421133C (en) | 2000-09-08 | 2012-06-26 | Insulet Corporation | Devices, systems and methods for patient infusion |
| DE60135042D1 (en) | 2000-11-09 | 2008-09-04 | Insulet Corp | Device for the transcutaneous delivery of drugs |
| CA2431420C (en) | 2000-12-21 | 2011-10-11 | Insulet Corporation | Medical apparatus remote control and method |
| US6726678B1 (en) * | 2001-02-22 | 2004-04-27 | Isurgical, Llc | Implantable reservoir and system for delivery of a therapeutic agent |
| EP1381408A4 (en) | 2001-02-22 | 2007-06-13 | Insulet Corp | Modular infusion device and method |
| US7083593B2 (en) * | 2001-04-18 | 2006-08-01 | Advanced Bionics Corporation | Programmable implantable pump with accessory reservoirs and multiple independent lumen catheter |
| KR100797144B1 (en) * | 2001-06-01 | 2008-01-22 | 아이-플로우 코포레이션 | Large volume bolus device and method |
| DE60239868D1 (en) | 2001-06-12 | 2011-06-09 | Univ Johns Hopkins Med | RESERVOIR DEVICE FOR INTRAOCULAR DRUG DELIVERY |
| US20040078028A1 (en) * | 2001-11-09 | 2004-04-22 | Flaherty J. Christopher | Plunger assembly for patient infusion device |
| AU2003208901A1 (en) * | 2002-02-01 | 2003-09-02 | The Cleveland Clinic Foundation | Microinfusion device |
| US6692457B2 (en) * | 2002-03-01 | 2004-02-17 | Insulet Corporation | Flow condition sensor assembly for patient infusion device |
| US6830558B2 (en) | 2002-03-01 | 2004-12-14 | Insulet Corporation | Flow condition sensor assembly for patient infusion device |
| US6656158B2 (en) | 2002-04-23 | 2003-12-02 | Insulet Corporation | Dispenser for patient infusion device |
| US20040153032A1 (en) * | 2002-04-23 | 2004-08-05 | Garribotto John T. | Dispenser for patient infusion device |
| US20050238507A1 (en) * | 2002-04-23 | 2005-10-27 | Insulet Corporation | Fluid delivery device |
| US6656159B2 (en) | 2002-04-23 | 2003-12-02 | Insulet Corporation | Dispenser for patient infusion device |
| US6960192B1 (en) | 2002-04-23 | 2005-11-01 | Insulet Corporation | Transcutaneous fluid delivery system |
| JP3854190B2 (en) * | 2002-04-26 | 2006-12-06 | 株式会社ジェイテクト | Motor control device |
| US6723072B2 (en) | 2002-06-06 | 2004-04-20 | Insulet Corporation | Plunger assembly for patient infusion device |
| US20050238506A1 (en) * | 2002-06-21 | 2005-10-27 | The Charles Stark Draper Laboratory, Inc. | Electromagnetically-actuated microfluidic flow regulators and related applications |
| US7018360B2 (en) | 2002-07-16 | 2006-03-28 | Insulet Corporation | Flow restriction system and method for patient infusion device |
| US7901419B2 (en) * | 2002-09-04 | 2011-03-08 | Allergan, Inc. | Telemetrically controlled band for regulating functioning of a body organ or duct, and methods of making, implantation and use |
| US7144384B2 (en) * | 2002-09-30 | 2006-12-05 | Insulet Corporation | Dispenser components and methods for patient infusion device |
| US7128727B2 (en) * | 2002-09-30 | 2006-10-31 | Flaherty J Christopher | Components and methods for patient infusion device |
| US20040116866A1 (en) * | 2002-12-17 | 2004-06-17 | William Gorman | Skin attachment apparatus and method for patient infusion device |
| US20050182366A1 (en) * | 2003-04-18 | 2005-08-18 | Insulet Corporation | Method For Visual Output Verification |
| US20050065760A1 (en) * | 2003-09-23 | 2005-03-24 | Robert Murtfeldt | Method for advising patients concerning doses of insulin |
| US20050070847A1 (en) * | 2003-09-29 | 2005-03-31 | Van Erp Wilhelmus Petrus Martinus Maria | Rapid-exchange balloon catheter with hypotube shaft |
| US9123077B2 (en) | 2003-10-07 | 2015-09-01 | Hospira, Inc. | Medication management system |
| US8065161B2 (en) | 2003-11-13 | 2011-11-22 | Hospira, Inc. | System for maintaining drug information and communicating with medication delivery devices |
| US7867194B2 (en) | 2004-01-29 | 2011-01-11 | The Charles Stark Draper Laboratory, Inc. | Drug delivery apparatus |
| US10207095B2 (en) * | 2004-12-14 | 2019-02-19 | C. R. Bard, Inc. | Fast clear port |
| US7491192B2 (en) * | 2004-12-30 | 2009-02-17 | C. R. Bard, Inc. | Cardiovascular access catheter with slit valve |
| US20060178633A1 (en) * | 2005-02-03 | 2006-08-10 | Insulet Corporation | Chassis for fluid delivery device |
| US9474888B2 (en) | 2005-03-04 | 2016-10-25 | C. R. Bard, Inc. | Implantable access port including a sandwiched radiopaque insert |
| EP1858565B1 (en) | 2005-03-04 | 2021-08-11 | C.R. Bard, Inc. | Access port identification systems and methods |
| US7947022B2 (en) | 2005-03-04 | 2011-05-24 | C. R. Bard, Inc. | Access port identification systems and methods |
| US8029482B2 (en) | 2005-03-04 | 2011-10-04 | C. R. Bard, Inc. | Systems and methods for radiographically identifying an access port |
| US10307581B2 (en) | 2005-04-27 | 2019-06-04 | C. R. Bard, Inc. | Reinforced septum for an implantable medical device |
| US8147455B2 (en) | 2005-04-27 | 2012-04-03 | C. R. Bard, Inc. | Infusion apparatuses and methods of use |
| EP2324880B1 (en) | 2005-04-27 | 2014-12-24 | C.R. Bard, Inc. | Infusion apparatuses provided with septum |
| US7552240B2 (en) * | 2005-05-23 | 2009-06-23 | International Business Machines Corporation | Method for user space operations for direct I/O between an application instance and an I/O adapter |
| US8034029B2 (en) | 2005-05-25 | 2011-10-11 | Palyon Medical (Bvi) Limited | Multi-reservoir implantable pump with patient controlled actuation |
| DE602006011000D1 (en) * | 2005-05-26 | 2010-01-21 | Infusion Systems Llc | IMPLANTABLE INFUSION DEVICE WITH SEVERAL CONTROLLABLE LIQUID OUTPUTS |
| US20070212397A1 (en) * | 2005-09-15 | 2007-09-13 | Roth Daniel B | Pharmaceutical delivery device and method for providing ocular treatment |
| US7708730B2 (en) * | 2006-01-30 | 2010-05-04 | Palyon Medical (Bvi) Limited | Template system for multi-reservoir implantable pump |
| US7972314B2 (en) * | 2006-03-29 | 2011-07-05 | Medical Components, Inc. | Venous access port base |
| AU2007317669A1 (en) | 2006-10-16 | 2008-05-15 | Hospira, Inc. | System and method for comparing and utilizing activity information and configuration information from mulitple device management systems |
| EP2081634B2 (en) * | 2006-10-18 | 2023-04-12 | Medical Components, Inc. | Venous access port assembly with radiopaque indicia |
| US9642986B2 (en) | 2006-11-08 | 2017-05-09 | C. R. Bard, Inc. | Resource information key for an insertable medical device |
| US9265912B2 (en) | 2006-11-08 | 2016-02-23 | C. R. Bard, Inc. | Indicia informative of characteristics of insertable medical devices |
| US9046192B2 (en) * | 2007-01-31 | 2015-06-02 | The Charles Stark Draper Laboratory, Inc. | Membrane-based fluid control in microfluidic devices |
| MX2009014100A (en) | 2007-06-20 | 2010-09-14 | Medical Components Inc | Venous access port with molded and/or radiopaque indicia. |
| US9610432B2 (en) | 2007-07-19 | 2017-04-04 | Innovative Medical Devices, Llc | Venous access port assembly with X-ray discernable indicia |
| MX2010000703A (en) | 2007-07-19 | 2010-07-29 | Medical Components Inc | Venous access port assembly with x-ray discernable indicia. |
| US9579496B2 (en) | 2007-11-07 | 2017-02-28 | C. R. Bard, Inc. | Radiopaque and septum-based indicators for a multi-lumen implantable port |
| US8100870B2 (en) * | 2007-12-14 | 2012-01-24 | Ethicon Endo-Surgery, Inc. | Adjustable height gastric restriction devices and methods |
| US9026370B2 (en) | 2007-12-18 | 2015-05-05 | Hospira, Inc. | User interface improvements for medical devices |
| JP5552585B2 (en) | 2008-04-17 | 2014-07-16 | アポロ エンドサージェリー，インコーポレイティド | IMPORTABLE ACCESS PORT DEVICE AND MOUNTING SYSTEM |
| US9023063B2 (en) * | 2008-04-17 | 2015-05-05 | Apollo Endosurgery, Inc. | Implantable access port device having a safety cap |
| DE102008030942A1 (en) * | 2008-07-02 | 2010-01-07 | Christoph Miethke Gmbh & Co Kg | Cerebrospinal fluid drainage |
| US7959598B2 (en) | 2008-08-20 | 2011-06-14 | Asante Solutions, Inc. | Infusion pump systems and methods |
| BRPI0919890B8 (en) * | 2008-10-31 | 2019-09-24 | Bard Inc C R | access port to provide subcutaneous access to a patient, and force injectable access port |
| US11890443B2 (en) | 2008-11-13 | 2024-02-06 | C. R. Bard, Inc. | Implantable medical devices including septum-based indicators |
| US8932271B2 (en) | 2008-11-13 | 2015-01-13 | C. R. Bard, Inc. | Implantable medical devices including septum-based indicators |
| EP2196231B1 (en) * | 2008-12-12 | 2013-02-27 | F. Hoffmann-La Roche AG | System for ambulatory drug infusion comprising a filling apparatus for flexible containers |
| US8623395B2 (en) | 2010-01-29 | 2014-01-07 | Forsight Vision4, Inc. | Implantable therapeutic device |
| EP2391419B1 (en) | 2009-01-29 | 2019-06-12 | ForSight Vision4, Inc. | Posterior segment drug delivery |
| US9370619B2 (en) | 2009-02-21 | 2016-06-21 | Incumed, Llc | Partially implantable medical devices and delivery/manifold tube for use with same |
| US8202260B2 (en) * | 2009-02-21 | 2012-06-19 | Incumed, Llc | Partially implantable medical devices with cartridge movement sensor and associated methods |
| US9125981B2 (en) * | 2009-02-21 | 2015-09-08 | Incumed, Llc | Fluid cartridges including a power source and partially implantable medical devices for use with same |
| US8271106B2 (en) | 2009-04-17 | 2012-09-18 | Hospira, Inc. | System and method for configuring a rule set for medical event management and responses |
| US8721605B2 (en) | 2009-04-27 | 2014-05-13 | The Alfred E. Mann Foundation For Scientific Research | Implantable infusion devices with palpable landmarks and methods of needle detection |
| WO2011005847A1 (en) * | 2009-07-07 | 2011-01-13 | C. R. Bard, Inc. | Extensible internal bolster for a medical device |
| US8715158B2 (en) * | 2009-08-26 | 2014-05-06 | Apollo Endosurgery, Inc. | Implantable bottom exit port |
| US8708979B2 (en) | 2009-08-26 | 2014-04-29 | Apollo Endosurgery, Inc. | Implantable coupling device |
| US8506532B2 (en) * | 2009-08-26 | 2013-08-13 | Allergan, Inc. | System including access port and applicator tool |
| JP2013510652A (en) | 2009-11-17 | 2013-03-28 | シー・アール・バード・インコーポレーテッド | Overmolded access port including locking feature and identification feature |
| US9579461B2 (en) | 2009-12-16 | 2017-02-28 | Becton, Dickinson And Company | Self-injection device |
| DK2512552T3 (en) | 2009-12-16 | 2015-06-08 | Becton Dickinson Co | Self Injection Device |
| EP3485929A1 (en) | 2009-12-16 | 2019-05-22 | Becton, Dickinson and Company | Self-injection device |
| ES2862501T3 (en) | 2009-12-16 | 2021-10-07 | Becton Dickinson Co | Self-injection device |
| JP5650755B2 (en) | 2009-12-16 | 2015-01-07 | ベクトン・ディキンソン・アンド・カンパニーＢｅｃｔｏｎ， Ｄｉｃｋｉｎｓｏｎ Ａｎｄ Ｃｏｍｐａｎｙ | Self injection device |
| CN102753233B (en) | 2009-12-16 | 2015-04-01 | 贝克顿·迪金森公司 | Self-injection device |
| US8771251B2 (en) * | 2009-12-17 | 2014-07-08 | Hospira, Inc. | Systems and methods for managing and delivering patient therapy through electronic drug delivery systems |
| US20110196195A1 (en) * | 2010-02-05 | 2011-08-11 | Allergan, Inc. | Implantable subcutaneous access port |
| US8882728B2 (en) * | 2010-02-10 | 2014-11-11 | Apollo Endosurgery, Inc. | Implantable injection port |
| US20110270021A1 (en) | 2010-04-30 | 2011-11-03 | Allergan, Inc. | Electronically enhanced access port for a fluid filled implant |
| US20110270025A1 (en) | 2010-04-30 | 2011-11-03 | Allergan, Inc. | Remotely powered remotely adjustable gastric band system |
| US8992415B2 (en) | 2010-04-30 | 2015-03-31 | Apollo Endosurgery, Inc. | Implantable device to protect tubing from puncture |
| AU2011285548B2 (en) | 2010-08-05 | 2014-02-06 | Forsight Vision4, Inc. | Combined drug delivery methods and apparatus |
| HUE057267T2 (en) | 2010-08-05 | 2022-05-28 | Forsight Vision4 Inc | Apparatus to treat an eye |
| PT2600930T (en) | 2010-08-05 | 2021-03-22 | Forsight Vision4 Inc | Injector apparatus and method for drug delivery |
| US20120041258A1 (en) | 2010-08-16 | 2012-02-16 | Allergan, Inc. | Implantable access port system |
| WO2012030316A1 (en) | 2010-09-02 | 2012-03-08 | Becton, Dickinson And Company | Self-injection device having needle cover with activation preventer |
| US20120065460A1 (en) | 2010-09-14 | 2012-03-15 | Greg Nitka | Implantable access port system |
| WO2012068549A2 (en) | 2010-11-19 | 2012-05-24 | Forsight Vision4, Inc. | Therapeutic agent formulations for implanted devices |
| USD682416S1 (en) | 2010-12-30 | 2013-05-14 | C. R. Bard, Inc. | Implantable access port |
| USD676955S1 (en) | 2010-12-30 | 2013-02-26 | C. R. Bard, Inc. | Implantable access port |
| US8876795B2 (en) | 2011-02-02 | 2014-11-04 | The Charles Stark Draper Laboratory, Inc. | Drug delivery apparatus |
| US8821373B2 (en) | 2011-05-10 | 2014-09-02 | Apollo Endosurgery, Inc. | Directionless (orientation independent) needle injection port |
| EP2726016B1 (en) | 2011-06-28 | 2023-07-19 | ForSight Vision4, Inc. | An apparatus for collecting a sample of fluid from a reservoir chamber of a therapeutic device for the eye |
| EP2739252A4 (en) | 2011-08-05 | 2015-08-12 | Forsight Vision4 Inc | Small molecule delivery with implantable therapeutic device |
| WO2013028497A1 (en) | 2011-08-19 | 2013-02-28 | Hospira, Inc. | Systems and methods for a graphical interface including a graphical representation of medical data |
| US8801597B2 (en) | 2011-08-25 | 2014-08-12 | Apollo Endosurgery, Inc. | Implantable access port with mesh attachment rivets |
| HUE054578T2 (en) | 2011-09-16 | 2021-09-28 | Forsight Vision4 Inc | Fluid exchange apparatus |
| US9199069B2 (en) | 2011-10-20 | 2015-12-01 | Apollo Endosurgery, Inc. | Implantable injection port |
| CA2852271A1 (en) | 2011-10-21 | 2013-04-25 | Hospira, Inc. | Medical device update system |
| US8858421B2 (en) | 2011-11-15 | 2014-10-14 | Apollo Endosurgery, Inc. | Interior needle stick guard stems for tubes |
| US9089395B2 (en) | 2011-11-16 | 2015-07-28 | Appolo Endosurgery, Inc. | Pre-loaded septum for use with an access port |
| WO2013090709A1 (en) | 2011-12-16 | 2013-06-20 | Hospira, Inc. | System for monitoring and delivering medication to a patient and method of using the same to minimize the risks associated with automated therapy |
| US8591456B2 (en) | 2011-12-28 | 2013-11-26 | Palyon Medical (Bvi) Limited | Multiple reservoir programmable pump |
| WO2013148798A1 (en) | 2012-03-30 | 2013-10-03 | Hospira, Inc. | Air detection system and method for detecting air in a pump of an infusion system |
| EP3549524B1 (en) | 2012-03-30 | 2023-01-25 | Insulet Corporation | Fluid delivery device with transcutaneous access tool, insertion mechanism and blood glucose monitoring for use therewith |
| EP2879733B1 (en) | 2012-07-31 | 2019-06-05 | ICU Medical, Inc. | Patient care system for critical medications |
| AU2014225658B2 (en) | 2013-03-06 | 2018-05-31 | Icu Medical, Inc. | Medical device communication method |
| AU2014236455B2 (en) | 2013-03-14 | 2018-07-12 | Forsight Vision4, Inc. | Systems for sustained intraocular delivery of low solubility compounds from a port delivery system implant |
| US9597227B2 (en) * | 2013-03-15 | 2017-03-21 | Abbott Medical Optics Inc. | Trans-sclera portal for delivery of therapeutic agents |
| EP2978393B1 (en) | 2013-03-28 | 2023-12-27 | ForSight Vision4, Inc. | Ophthalmic implant for delivering therapeutic substances |
| WO2014190264A1 (en) | 2013-05-24 | 2014-11-27 | Hospira, Inc. | Multi-sensor infusion system for detecting air or an occlusion in the infusion system |
| AU2014274146B2 (en) | 2013-05-29 | 2019-01-24 | Icu Medical, Inc. | Infusion system which utilizes one or more sensors and additional information to make an air determination regarding the infusion system |
| EP3003442B1 (en) | 2013-05-29 | 2020-12-30 | ICU Medical, Inc. | Infusion system and method of use which prevents over-saturation of an analog-to-digital converter |
| AU2014312122A1 (en) | 2013-08-30 | 2016-04-07 | Icu Medical, Inc. | System and method of monitoring and managing a remote infusion regimen |
| US9662436B2 (en) | 2013-09-20 | 2017-05-30 | Icu Medical, Inc. | Fail-safe drug infusion therapy system |
| US10311972B2 (en) | 2013-11-11 | 2019-06-04 | Icu Medical, Inc. | Medical device system performance index |
| US10042986B2 (en) | 2013-11-19 | 2018-08-07 | Icu Medical, Inc. | Infusion pump automation system and method |
| ES2776363T3 (en) | 2014-02-28 | 2020-07-30 | Icu Medical Inc | Infusion set and method using dual wavelength in-line optical air detection |
| US9764082B2 (en) | 2014-04-30 | 2017-09-19 | Icu Medical, Inc. | Patient care system with conditional alarm forwarding |
| US11344673B2 (en) | 2014-05-29 | 2022-05-31 | Icu Medical, Inc. | Infusion system and pump with configurable closed loop delivery rate catch-up |
| US9724470B2 (en) | 2014-06-16 | 2017-08-08 | Icu Medical, Inc. | System for monitoring and delivering medication to a patient and method of using the same to minimize the risks associated with automated therapy |
| MY182793A (en) | 2014-08-08 | 2021-02-05 | Forsight Vision4 Inc | Stable and soluble formulations of receptor tyrosine kinase inhibitors, and methods of preparation thereof |
| US9539383B2 (en) | 2014-09-15 | 2017-01-10 | Hospira, Inc. | System and method that matches delayed infusion auto-programs with manually entered infusion programs and analyzes differences therein |
| US11344668B2 (en) | 2014-12-19 | 2022-05-31 | Icu Medical, Inc. | Infusion system with concurrent TPN/insulin infusion |
| US10850024B2 (en) | 2015-03-02 | 2020-12-01 | Icu Medical, Inc. | Infusion system, device, and method having advanced infusion features |
| ES2845725T3 (en) | 2015-05-26 | 2021-07-27 | Icu Medical Inc | Infusion pump system and method with multiple drug library editor source capability |
| CA3005238A1 (en) | 2015-11-20 | 2017-05-26 | Forsight Vision4, Inc. | Porous structures for extended release drug delivery devices |
| US10716896B2 (en) | 2015-11-24 | 2020-07-21 | Insulet Corporation | Wearable automated medication delivery system |
| US10413665B2 (en) | 2015-11-25 | 2019-09-17 | Insulet Corporation | Wearable medication delivery device |
| WO2017123525A1 (en) | 2016-01-13 | 2017-07-20 | Bigfoot Biomedical, Inc. | User interface for diabetes management system |
| EP3453414A1 (en) | 2016-01-14 | 2019-03-13 | Bigfoot Biomedical, Inc. | Adjusting insulin delivery rates |
| ES2912378T3 (en) | 2016-05-13 | 2022-05-25 | Icu Medical Inc | Common Line Auto Purge Infusion Pump System |
| EP3646905B1 (en) | 2016-05-26 | 2021-06-23 | Insulet Corporation | Single dose drug delivery device |
| WO2017214441A1 (en) | 2016-06-10 | 2017-12-14 | Icu Medical, Inc. | Acoustic flow sensor for continuous medication flow measurements and feedback control of infusion |
| NZ750032A (en) | 2016-07-14 | 2020-05-29 | Icu Medical Inc | Multi-communication path selection and security system for a medical device |
| WO2018031891A1 (en) | 2016-08-12 | 2018-02-15 | Insulet Corporation | Plunger for drug delivery device |
| EP3496787B1 (en) | 2016-08-14 | 2020-07-08 | Insulet Corporation | Drug delivery device with detection of position of the plunger |
| WO2018067645A1 (en) | 2016-10-07 | 2018-04-12 | Insulet Corporation | Multi-stage delivery system |
| US10780217B2 (en) | 2016-11-10 | 2020-09-22 | Insulet Corporation | Ratchet drive for on body delivery system |
| WO2018136699A1 (en) | 2017-01-19 | 2018-07-26 | Insulet Corporation | Cartridge hold-up volume reduction |
| US11045603B2 (en) | 2017-02-22 | 2021-06-29 | Insulet Corporation | Needle insertion mechanisms for drug containers |
| US10695485B2 (en) | 2017-03-07 | 2020-06-30 | Insulet Corporation | Very high volume user filled drug delivery device |
| US10835688B2 (en) | 2017-08-01 | 2020-11-17 | Tejash Patel | Enhanced needle |
| WO2019028342A1 (en) | 2017-08-03 | 2019-02-07 | Insulet Corporation | Micro piston pump |
| US10973978B2 (en) | 2017-08-03 | 2021-04-13 | Insulet Corporation | Fluid flow regulation arrangements for drug delivery devices |
| US11786668B2 (en) | 2017-09-25 | 2023-10-17 | Insulet Corporation | Drug delivery devices, systems, and methods with force transfer elements |
| WO2019067367A1 (en) | 2017-09-26 | 2019-04-04 | Insulet Corporation | Needle mechanism module for drug delivery device |
| US11147931B2 (en) | 2017-11-17 | 2021-10-19 | Insulet Corporation | Drug delivery device with air and backflow elimination |
| KR20200093581A (en) | 2017-11-21 | 2020-08-05 | 포사이트 비젼4, 인크. | Fluid exchange devices and methods of use for scalable port delivery systems |
| US10089055B1 (en) | 2017-12-27 | 2018-10-02 | Icu Medical, Inc. | Synchronized display of screen content on networked devices |
| US10874803B2 (en) | 2018-05-31 | 2020-12-29 | Insulet Corporation | Drug cartridge with drive system |
| US11229736B2 (en) | 2018-06-06 | 2022-01-25 | Insulet Corporation | Linear shuttle pump for drug delivery |
| CA3106516C (en) | 2018-07-17 | 2023-07-25 | Icu Medical, Inc. | Updating infusion pump drug libraries and operational software in a networked environment |
| US11139058B2 (en) | 2018-07-17 | 2021-10-05 | Icu Medical, Inc. | Reducing file transfer between cloud environment and infusion pumps |
| NZ772135A (en) | 2018-07-17 | 2022-11-25 | Icu Medical Inc | Systems and methods for facilitating clinical messaging in a network environment |
| US11152109B2 (en) | 2018-07-17 | 2021-10-19 | Icu Medical, Inc. | Detecting missing messages from clinical environment |
| US10692595B2 (en) | 2018-07-26 | 2020-06-23 | Icu Medical, Inc. | Drug library dynamic version management |
| AU2019309766A1 (en) | 2018-07-26 | 2021-03-18 | Icu Medical, Inc. | Drug library management system |
| US11446435B2 (en) | 2018-11-28 | 2022-09-20 | Insulet Corporation | Drug delivery shuttle pump system and valve assembly |
| US11369735B2 (en) | 2019-11-05 | 2022-06-28 | Insulet Corporation | Component positioning of a linear shuttle pump |
| US11278671B2 (en) | 2019-12-04 | 2022-03-22 | Icu Medical, Inc. | Infusion pump with safety sequence keypad |
| CA3189781A1 (en) | 2020-07-21 | 2022-01-27 | Icu Medical, Inc. | Fluid transfer devices and methods of use |
| US11135360B1 (en) | 2020-12-07 | 2021-10-05 | Icu Medical, Inc. | Concurrent infusion with common line auto flush |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3769982A (en) * | 1971-09-24 | 1973-11-06 | R Schulte | Physiological drainage system with closure means responsive to downstream suction |
| US3827439A (en) * | 1972-10-30 | 1974-08-06 | Heyer Schulte Corp | Plug valve for physiological shunt systems |
| US4013074A (en) * | 1974-06-21 | 1977-03-22 | Siposs George G | Implantable medication-dispensing device |
| US4190040A (en) * | 1978-07-03 | 1980-02-26 | American Hospital Supply Corporation | Resealable puncture housing for surgical implantation |
| US4258711A (en) * | 1979-02-05 | 1981-03-31 | Metal Bellows Corporation | Infusion apparatus and method |
| US4265241A (en) * | 1979-02-28 | 1981-05-05 | Andros Incorporated | Implantable infusion device |
| US4437457A (en) * | 1982-04-27 | 1984-03-20 | Medical Engineering Corporation | Artificial sphincter with improved pressure control valve |
| US4544371A (en) * | 1982-10-05 | 1985-10-01 | American Hospital Supply Corporation | Implantable metered dose drug delivery system |
| NL8400489A (en) * | 1983-11-23 | 1985-06-17 | Cordis Corp | MANUAL, BODY-IMPLANTABLE DOSING DEVICE FOR A FLOWABLE MEDICINE. |
-
1984
- 1984-09-04 US US06/646,998 patent/US4634427A/en not_active Expired - Fee Related
-
1985
- 1985-08-20 DE DE198585305922T patent/DE174757T1/en active Pending
- 1985-08-20 EP EP85305922A patent/EP0174757A1/en not_active Withdrawn
- 1985-09-03 JP JP60194713A patent/JPS61113469A/en active Pending
- 1985-09-04 CA CA000489971A patent/CA1243245A/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| JPS61113469A (en) | 1986-05-31 |
| EP0174757A1 (en) | 1986-03-19 |
| US4634427A (en) | 1987-01-06 |
| DE174757T1 (en) | 1986-09-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1243245A (en) | Implantable demand medication delivery assembly | |
| US4544371A (en) | Implantable metered dose drug delivery system | |
| US5152753A (en) | Medication infusion device with dose recharge restriction | |
| US5085644A (en) | Sterilizable medication infusion device with dose recharge restriction | |
| US4681560A (en) | Subcutaneous infusion reservoir and pump system | |
| US4816016A (en) | Subcutaneous infusion reservoir and pump system | |
| US4588394A (en) | Infusion reservoir and pump system | |
| US4687468A (en) | Implantable insulin administration device | |
| US5188603A (en) | Fluid infusion delivery system | |
| US4699615A (en) | Finger actuated medication infusion system | |
| US5053031A (en) | Pump infusion system | |
| EP0291612B1 (en) | Implantable pump. | |
| US6679832B1 (en) | Implantable device for treating impotence by delivering a vasodilator agent to the erectile bodies of the penis | |
| JP3147347B2 (en) | Chemical self-injection tool | |
| JPH0537072B2 (en) | ||
| JP4539382B2 (en) | Patient controlled analgesia (PCA) device with continuous infusion and additional administration | |
| AU2021203345B2 (en) | Medical liquid administration device | |
| US4761158A (en) | Subcutaneous infusion reservoir and pump system | |
| EP0951307A1 (en) | Drug delivery means | |
| US6360784B1 (en) | Valved connector and method of use | |
| US4710177A (en) | Subcutaneous ventricular injection apparatus and method | |
| CA1238830A (en) | Implantable insulin administration device | |
| CA1333144C (en) | Implantable drug delivery system | |
| EP0143503B1 (en) | Implantable hand-operable dispensers for fluid medicaments | |
| JP3147346B2 (en) | Chemical self-injection tool |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MKEX | Expiry |